Feyza SEVER, Sevil TOKAT, Mine AKIN, Devrim Tanıl KURT, Gülsen KESKİN, Sibel SAYDAM, Sengül ÖZMERT, Murat KIZILGÜN, Arif Osman TOKAT

TÜRK‹YE'DE PED‹YATR‹K HASTALARDA PSÖDOKOL‹NESTERAZ EKS‹KL‹⁄‹ VE KATKIDA BULUNAN FAKTÖRLER‹N ‹NS‹DANSI

Amaç: Genel anestezi uygulamalar›nda gözlenen olas› komplikasyonlar aç›s›ndan oldukça önemli olan psödokolinesteraz (PKE) eksikli¤i s›kl›¤›n› ortaya koymak amaçlanm›flt›r. Yöntem: Hastalar›n kay›tlar› (yafl, cinsiyet, serum PKE etki düzeyleri, karaci¤er ve böbrek fonksiyonlar›) bilgisayar ortam›nda yap›ld› ve veriler üzerinde çal›fl›ld›. Bulgular: Hastalar›n %5.5'inde (n = 15.309) PKE düzeyi normal de¤erlerin alt›ndayd›. PKE eksikli¤i yüzdesi, yüksek alanin amino transferaz, aspartat amino transferaz, üre ve kreatinin düzeyleri olan hastalarda yüksek bulundu (p

THE INCIDENCE OF PSEUDOCHOLINESTERASE DEFICIENCY AND CONTRIBUTING FACTORS IN PEDIATRIC PATIENTS IN TURKEY

Objective: It is aimed to reveal the frequency of pseudocholinesterase (PCE) deficiency, which is highly important for thepossible complications observed during the general anaesthesia applications.Method: The records of patients (age, sex, serum PCE effect levels, liver and kidney functions) were computerized and studiedon the data.Results: PCE level in 5.5% of the patients (n=15.309) were under the normal values. The PCE deficiency percentage washigh with high alanine amino transferase, aspartate amino transferase, ure and creatinin levels (p

PDF

___

Kalow W. Heritable factors recognized in man by the use of drugs. In: Kalow W (ed). Pharmacogenetics: Heredity and the Response to Drugs. Philadelphia: WB Saunders Co, 1962: 69-136.
Davis L, Britten JJ, Morgan N. Cholinesterase: its significance in anesthetic practice. Anesthesia 1997; 52: 244-260.
Ama T, Bounmythavong S, Blaze J, Weismann M, Marienau MS, Nicholson WT. Implications of pharmacogenomics for anesthesia providers. AANA J 2010; 78: 393-399.
Kaufman L, Lehmann H, Silk E. Suxamethonium apnea in an infant. Expression of familial pseudocholinesterase deficiency in three generations. Br Med J 1960; 16: 166-167.
Templeton AR. The theory of speciation via the founder principle. Genetics 1980; 94: 1011-1038.
Manoharan I, Wieseler S, Layer PG, Layer PG, Lockridge O, Boopathy R. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India. Pharmacogenet Genomics 2006; 16: 461-468.
Scott EM, Wright RC. A third type of serum cholinesterase deficiency in Eskimos. Am J Hum Genet 1976; 28: 253-256.
Sayek ‹, Karahasano¤lu AM, Özand P. Pseudocholinesterase. 3. The presence of pseudocholinesterase variants in a Turkish population. Turk J Pediatr 1967; 9: 8-12.
Kutty KM, Payne RH. Serum pseudocholinesterase and very- low-density lipoprotein metabolism. J Clin Lab Anal 1994; 8: 247-250.
Kaya G, Akef A, Atalay A. [Pseudocholinesterase activity and genetic variants at 202 volunteers in Sivas]. Cumhuriyet Med J 2000; 22: 93-97.
Y›ld›r›m S, fiahin AF, Döngel ‹, Erflan ‹, Özkan F. Sivas ilinde psödokolinesteraz eksikli¤i görülme s›kl›¤› ve iliflkili klinik parametreler. Türkiye Klinikleri J Anest 2012; 10: 84-88.
Oropollo AT. Abnormal pseudocholinesterase levels in surgical population. Anesthesiology 1978; 48: 284-286.
Smith CL, Hunter JM, Jones RS. Prolonged paralysis following an infusion of alcuronium in a patient with renal dysfunction. Anaesthesia 1987; 42: 522-555.
Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail’s Clinical Anesthesiology. Postanesthesia Care CH: 56. The McGraw-Hill Companies 2013: 1257-1276.
Ghazal E, Amin A, Wu A, Felema B, Applegate II RL. Impact of rocuronium vs succinylcholine neuromuscular blocking drug choice for laparoscopic pyloromyotomy: is there a difference in time to transport to recovery? Pediatric Anesthesia 2013; 23: 316-321.
Turkkal D. C, Gokmen N, Y›ldiz A et al. A cross-over, post- electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine. J Clin Anesth 2009; 20: 589-593.
Ledowski T, Hillyard S, Kozman A et al. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs. Anaesth Intensive Care 2012; 40: 340-343.
Omur D, Kiraz HA, Sahin H et al. Use of succinylcholine by anaesthetists in Turkey: A National Survey. Turk J Anaesthesiol Reanim 2015; 43: 323-331.